Paradigm Capital Management Inc. NY Sells 228,889 Shares of TruBridge, Inc. (NASDAQ:TBRG)

Paradigm Capital Management Inc. NY lowered its stake in TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 70.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 95,000 shares of the company's stock after selling 228,889 shares during the quarter. Paradigm Capital Management Inc. NY owned approximately 0.64% of TruBridge worth $1,873,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Federated Hermes Inc. grew its stake in shares of TruBridge by 3.1% in the fourth quarter. Federated Hermes Inc. now owns 468,758 shares of the company's stock valued at $9,244,000 after buying an additional 14,120 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in TruBridge by 12.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 348,941 shares of the company's stock valued at $6,881,000 after acquiring an additional 38,902 shares during the last quarter. Truffle Hound Capital LLC bought a new position in shares of TruBridge in the 4th quarter valued at about $5,916,000. D. E. Shaw & Co. Inc. raised its holdings in shares of TruBridge by 8.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 217,539 shares of the company's stock valued at $4,290,000 after purchasing an additional 16,821 shares during the period. Finally, Susquehanna International Group LLP raised its stake in TruBridge by 343.6% in the fourth quarter. Susquehanna International Group LLP now owns 209,871 shares of the company's stock valued at $4,139,000 after buying an additional 162,560 shares during the period. Institutional investors own 88.64% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on TBRG shares. Cantor Fitzgerald lifted their price objective on shares of TruBridge from $20.00 to $29.00 and gave the stock an "overweight" rating in a research report on Tuesday, March 11th. Stephens reiterated an "equal weight" rating and issued a $28.00 price target on shares of TruBridge in a research note on Thursday, April 10th.

TruBridge Stock Performance

TBRG stock traded up $0.04 during trading hours on Friday, hitting $23.73. 310,679 shares of the stock were exchanged, compared to its average volume of 128,771. TruBridge, Inc. has a 12 month low of $8.99 and a 12 month high of $32.00. The company has a current ratio of 1.80, a quick ratio of 1.78 and a debt-to-equity ratio of 1.00. The firm has a market capitalization of $356.50 million, a P/E ratio of -5.80, a P/E/G ratio of 5.38 and a beta of 0.65. The company has a 50-day simple moving average of $25.66 and a two-hundred day simple moving average of $23.37.

TruBridge (NASDAQ:TBRG - Get Free Report) last released its quarterly earnings results on Friday, May 9th. The company reported $0.29 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.08). The business had revenue of $87.21 million for the quarter, compared to the consensus estimate of $86.21 million. TruBridge had a positive return on equity of 1.78% and a negative net margin of 17.72%. On average, analysts forecast that TruBridge, Inc. will post 0.07 earnings per share for the current fiscal year.

Insider Activity at TruBridge

In other TruBridge news, CEO Christopher L. Fowler sold 6,000 shares of the firm's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $25.05, for a total value of $150,300.00. Following the sale, the chief executive officer now owns 131,090 shares of the company's stock, valued at approximately $3,283,804.50. This trade represents a 4.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 10.70% of the stock is owned by insiders.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.